Faculty Profile for Dr. Liqin Du

profile photo for Dr. Liqin Du
Dr. Liqin Du
Associate Professor — Chemistry and Biochemistry
CHEM 212
phone: (512) 245-1038

Biography Section

Biography and Education

2009: Postdoctoral Fellow, McDermott Center for Human Growth and Development, UT Southwestern Medical Center at Dallas, Dallas, TX.

2004: Nutritional Sciences, University of Kentucky, Lexington, KY.

1998: Master of Medicine, Shanghai Second Medical University, Shanghai, China.

1992: Bachelor of Medicine (MD equivalent), Shanghai Medical University, Shanghai, China.

Teaching Interests

1, Molecular Biology; 2, Cancer Biology; 3, Cell Biology; 4, Biochemistry.

Research Interests

1, Cell differentiation in childhood tumorigenesis; 2, Differentiation therapy; 3, Natural products as anti-cancer agents; 4, Synthetic small-molecular compounds as anti-cancer agents; 5, non-coding RNAs in tumorigenesis and cancer therapy

Selected Scholarly/Creative Work

  • Zhao, G., Du, L., Zhang, L., & Jia, Y. (2021). LIM domain only 1: an oncogenic transcription cofactor contributing to the tumorigenesis of multiple cancer types. Chinese Medicine Journal, 134(9), 1017–1030. https://doi.org/10.1097/CM9.0000000000001487
  • Zhao, Z., Shelton, S. D., Oviedo, A., Baker, A. L., Bryant, C. P., Omidvarnia, S., & Du, L. (2020). The PLAGL2/MYCN/miR-506-3p interplay regulates neuroblastoma cell fate and associates with neuroblastoma progression. Journal of Experimental and Clinical Cancer Research, 39(1), 41. https://doi.org/10.1186/s13046-020-1531-2.
  • Cardus, D. F., Smith, M. T., Vernaza, A., Smith, J. L., Del Buono, B., Parajuli, A., … Du, L. (2024). Systematic Analysis of miR-506-3p Target Genes Identified Key Mediators of Its Differentiation-Inducing Function. Genes, 15(10), 1–13. Retrieved from DOI: 10.3390/genes15101268
  • Saucedo, A., Subbarao, M., Jemal, M. J., Mesa-Diaz, N. L., Smith, J. L., Vernaza, A., … Kerwin, S. M. (2024). Flow and On-Water Synthesis and Cancer Cell Cytotoxicity of Caffeic Acid Phenethyl Amide (CAPA) Derivatives. Int J Mol Sci., 25(15), 1–11. https://doi.org/10.3390/genes15101268
  • Aksenov, D. A., Smith, J. L., Aksenov, A. V., Prityko, L. A., Aksenov, N. A., Kuzminov, I. K., … Kornienko, A. V. (2024). 2-(3-Indolyl)acetamides and their oxazoline analogues: Anticancer SAR study. Bioorg Med Chem Lett., 102, 1–6. https://doi.org/10.1016/j.bmcl.2024.129681

Selected Awards

  • Award / Honor Recipient: 2024F Presidential Research Award for Faculty Development Leave, Texas State University. July 2, 2024 - May 31, 2025
  • Award / Honor Recipient: Hua Rui Prize, Sino-Swed Pharmaceutical Corp. Ltd. 1997
  • Award / Honor Recipient: Scholarship for Outstanding Graduate, Shanghai Second Medical University, China. 1996
  • Award / Honor Recipient: Scholarship for Outstanding Graduate, Shanghai Second Medical University, China. 1995
  • Award / Honor Recipient: First Prize of People’s Scholarship, Shanghai Medical University, China. 1991

Selected Grants

  • Du, Liqin (Principal). Molecular and therapeutic mechanisms of differentiation-inducing microRNA miR-506-3p in neuroblastoma, National Institute of Health, NCI, R15, Federal, $445639. (Submitted: June 6, 2019, Funded: September 1, 2020 - August 31, 2024). Grant.
  • Du, Liqin (Principal), Kornienko, Alexander (Other), Houhgton, Peter (Other). Discovery of new differentiation agents for neuroblastoma therapy, National Institute of Health, NCI, R15, resubmissiom, Federal, $461574. (Funded: August 1, 2017 - July 31, 2020). Grant.
  • Du, Liqin (Principal). Targeting the human druggable genome for neuroblastoma differentiation therapy, Texas State University, REP Program, Texas State University, $8000. (Submitted: October 9, 2024, Funded: January 27, 2025 - May 31, 2026). Grant.
  • Du, Liqin (Principal). Developing new research directions in my laboratory, Texas State University, Presidential Research Award, Texas State University, $20000. (Submitted: September 15, 2023, Funded: July 2, 2024 - May 31, 2025). Grant.
  • Peterson, Ryan Loren, Lewis, Lysle, Du, Liqin, McLean, Robert J C. Fluorescence Microscope with Live-cell and high-resolution imaging capabilities, NIH, Federal, $194590.3. (Funded: July 1, 2024 - June 30, 2025). Grant.

Selected Service Activities

Member
Department Space Committee
2021-Present
Member
Department Personnel Committee
2021-Present
Member
COSE Undergraduate Scholarship Committee
2021-Present
Editorial Review Board Member
Technology in Cancer Research and Treatment (TCRT)
October 2021-Present
Member
Biochemistry Graduate Curriculum committee
2016-Present